Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Navlimetostat (BMS-986504) Drug Interactions and Food Effect in Healthy Participants
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to assess the food effect and drug interactions on drug levels of Navlimetostat in health adult female participants
Official title: A Phase 1, Open-label, Randomized, Pharmacokinetic Study to Assess the Drug Interactions and Food Effect of Navlimetostat (BMS-986504) in Healthy Female Participants
Key Details
Gender
FEMALE
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-08-26
Completion Date
2027-03-25
Last Updated
2026-09-02
Healthy Volunteers
Yes
Conditions
Interventions
Navlimetostat
Specified dose on specified days
Itraconazole
Specified dose on specified days
Rifampin
Specified dose on specified days
Midazolam
Specified dose on specified days
Pantoprazole
Specified dose on specified days